Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
---|---|---|---|---|---|---|---|
Imatinib | ADORA2A-AS1 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | CCDC26 | lncRNA | sensitive | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | circ_0009910 | circRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | circBA9.3 | circRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | ebv-miR-BART13-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | ebv-miR-BART18-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | H19 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hcmv-miR-US25-1-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | HOTAIR | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | HOTAIR | lncRNA | resistant | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7a-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7a-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7b | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7b-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7c | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7d | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7d | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7d-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7e | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7e-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7f-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7i | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7i | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-let-7i | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-let-7i-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1-3p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-100-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-100* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-101-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-103a-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-103a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-106b-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-107 | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-107 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-10a-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-10a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1200 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-1207 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-1224 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-1225 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1226-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1228-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1228-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1228-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1249-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1249-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1258 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-125a-5p | miRNA | resistant | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-125a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-125a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-125a-5p | miRNA | resistant | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-125b-2 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-125b-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1260b | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1268a | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1269a | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1275 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1277-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-128-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1280 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1285-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1288-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1293 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1293 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1299 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1299 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1301-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1303 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1306-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-130a-3p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-130a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-130b | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-130b-3p | miRNA | sensitive | High | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-130b-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-132-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1321 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1323 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1325 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-134-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-135b-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-135b-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-136-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-138-2-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-139-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-139-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-140-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-140-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-142-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-142-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-142-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-142-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-143-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-143-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-143-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-144-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-145 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-146a-5p | miRNA | sensitive | High | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-146a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-146b-3p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-146b-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-146b-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-148a-3p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-148b-3p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-149-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-150-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-150-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-151a-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-151a-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-151a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-151a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-155-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-15a-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-15a-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-15b-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-16-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1669 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-17-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1725-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-1803 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-181a-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-181b-5p | miRNA | sensitive | Low | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-181c-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-181c-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-181c-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-181d-5p | miRNA | sensitive | Low | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-183-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-185-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-186-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-188-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-188-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-18a | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-18b-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-190a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1910-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1915-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-192-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-193a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-193b-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-195-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-195-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-196a-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1973 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-199a-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-199a-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-199b-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-199b-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-199b-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-19a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-19b-1-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-200a-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-200c-3p | miRNA | sensitive | Low | Clear Cell Renal Cell Carcinoma | Homo sapiens | |
Imatinib | hsa-miR-202-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-202-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-203a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-203a-3p | miRNA | sensitive | Low | Glioblastoma | Homo sapiens | |
Imatinib | hsa-miR-204-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-20a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-20b-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-21-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-21-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-210-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-210-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-210-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2114-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2115-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2117 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-212-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-212-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-214-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-214-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-214-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-218-5p | miRNA | sensitive | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-218-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-218-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-219a-2-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-219b-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-221-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-221-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-221-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-222-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-223 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-223-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-224-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2277-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2278 | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2278 | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2355-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-2355* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-2392 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-23b-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-24-1-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-25-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-25-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-26a-1 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-26a-5p | miRNA | sensitive | High | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-26a-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-26b-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-26b-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-27a-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-27b-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-27b-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-296-5p | miRNA | sensitive | Low | Glioblastoma | Homo sapiens | |
Imatinib | hsa-miR-296-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-298 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-298 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-29a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-29b-1-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-29b-3p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-29b-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-29c-3p | miRNA | sensitive | High | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-301a-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-302a-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-302c-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-302d-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-30a | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | sensitive | Low | Giant Cell Tumor | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30b-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-30b-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-30c-1-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30c-2-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30c-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-30c-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30e-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30e-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3117-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3119 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3127-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3131 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3133 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3145a-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3157-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3165 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-3173* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3184-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3187-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3196 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3197 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-320a-3p | miRNA | sensitive | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-320a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-320a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-320e | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-323b* | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-324 | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-324 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-325 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-33-pre | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-331-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-331-pre | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-335-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-335-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-335-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-337* | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-338-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-338-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-339 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-33a-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-340 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-340-3p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-340-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-342 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-342-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-342-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-345 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-345-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-34a-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-34c-5p | miRNA | resistant | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-34c-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-3607 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3607-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3615 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-362-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-362-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-362-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3621 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3655 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3656 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-365a-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-365a-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-365a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-365b-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3661 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3675-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3679-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-3688-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3688-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-370-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-371a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-374a-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-376a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-376c-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-378a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-378c | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-379-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-379-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-379-pre | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-381-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-382-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3907 | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-3913-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-411-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-411-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-411-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-422a-pre | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-423-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-424-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4251 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4259 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4274 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4285 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4290 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4294 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4301 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4303 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4308 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4313 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4325 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4327 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4433a-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4433a-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4433b-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4436a | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4444 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4445a-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4446-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4466 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4476 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4477a | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4492 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-450a-1-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-450a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4511 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4513 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-451a | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-451a | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-451a | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-4521 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-4536-1 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4639-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4645-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4651 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-4662a* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4667-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4673 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4710 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4716-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4722-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4722-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4732-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4742-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-4766-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4783-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-4789-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-483-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-483-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-485-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-486-5p | miRNA | sensitive | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib | hsa-miR-486-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-491-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-493-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-493-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-494-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-498-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-5004-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-5010-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-5047 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-505* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-508-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-509-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-510-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-512-2-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-517-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-518a-5p | miRNA | sensitive | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-518a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-518e-5p | miRNA | resistant | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-519a-1-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-519c-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-519d-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-520a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-520c-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-520c-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-520e-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-522-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-523-pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-525-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-525-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-532-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-532-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-542-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-545-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-5481 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-548b-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-548c-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-548e-3p | miRNA | resistant | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-548q | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-550a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-555-Pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-557 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-5588-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-5683 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-5701 | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-574-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-574-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-583 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-584-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-585-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-586-Pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-588-Pre | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-589-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-593-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-595 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-595 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-596 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-598 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-604 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-605* | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-608 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-613 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-624-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-625-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-625-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-629-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-629-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-636 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-636 | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-638 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-642a-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-642a-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-642a-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-642b-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-645 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-647 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-6502-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-6511b-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-652-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-654-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-658 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-mir-660 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-660-5p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-660-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-663a | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-664a-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-664a-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-671-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-671-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-675-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-675-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-676-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-6782-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-6810-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-6813-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-7-2-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-711 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-711 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-718 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-761 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-761 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-762 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-764 | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-766-3p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-766-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-766-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-767-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-7849-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-874-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-874-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-mir-874* | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-877-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-888-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-9-3p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-9-3p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-9-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-9-5p | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-922 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-92b-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-937-3p | miRNA | resistant | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-939-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-96-5p | miRNA | sensitive | High | Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-96-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-99a-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-99b-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-H1-5p | miRNA | sensitive | High | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miRPlus-A1072 | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miRPlus-I874* | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0000367 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0000595 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0001402 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0001788 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0002191 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0004885 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0006614 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0008274 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0009117 | circRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0010921 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0020929 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0020934 | circRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0024517 | circRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0026686 | circRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0030062 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0038737 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0042819 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0044097 | circRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0045881 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0049613 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0056754 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0058493 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0068367 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_0083054 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa_circ_404457 | circRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsv1-miR-H6-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsv2-miR-H25 | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsv2-miR-H7-3p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsv2-miR-H7-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | HULC | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | kshv-miR-K12-3-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | kshv-miR-K12-5-5p | miRNA | resistant | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | lnc-ATP7A-1 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-ATP7A-2 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-FAM108B1-3 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-OMD-1 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-RERE-4 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-TCF4-6 | lncRNA | sensitive | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-TCP1-5 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | lnc-TERT-2 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | LNC000093 | lncRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | LNC000114 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | MALAT1 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | MEG3 | lncRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | mmu-miR-134-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Mus musculus | |
Imatinib | NONHSAG016304 | lncRNA | sensitive | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | THBS1-IT1 | lncRNA | resistant | High | Primary Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | OIP5-AS1 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | PANTR1 | lncRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | sv40-miR-S1-5p | miRNA | sensitive | High | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | UCA1 | miRNA | resistant | Low | Chronic Myelogenous Leukemia | Homo sapiens |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Compound | ncRNA | Symbol | pattern | log2FC | p-value | Detail |
---|---|---|---|---|---|---|
Imatinib | ENSG00000132832 | KCNK15-AS1 | resistant | 3.4945 | 0.0457 | |
Imatinib | ENSG00000167912 | TOX-DT | sensitive | -2.8845 | 0.0232 | |
Imatinib | ENSG00000175701 | MTLN | resistant | 3.2308 | 0.042 | |
Imatinib | ENSG00000180139 | ACTA2-AS1 | sensitive | -3.885 | 0.031 | |
Imatinib | ENSG00000186019 | ZNF225-AS1 | sensitive | -2.0901 | 0.0207 | |
Imatinib | ENSG00000196553 | CCDC196 | resistant | 2.3236 | 0.0061 | |
Imatinib | ENSG00000196553 | CCDC196 | sensitive | -1.8017 | 0.0132 | |
Imatinib | ENSG00000197813 | resistant | 3.6643 | 0.0048 | ||
Imatinib | ENSG00000205890 | resistant | 2.2659 | 0.0312 | ||
Imatinib | ENSG00000206028 | sensitive | -2.0005 | 0.0303 | ||
Imatinib | ENSG00000213904 | LIPE-AS1 | sensitive | -1.2442 | 0.0401 | |
Imatinib | ENSG00000214770 | sensitive | -1.349 | 0.0412 | ||
Imatinib | ENSG00000214851 | LINC00612 | sensitive | -2.7096 | 0.0464 | |
Imatinib | ENSG00000215190 | LINC00680 | sensitive | -1.0573 | 0.0391 | |
Imatinib | ENSG00000215447 | LINC00205 | sensitive | -1.1251 | 0.0237 | |
Imatinib | ENSG00000219665 | ZNF433-AS1 | sensitive | -4.0508 | 0.0463 | |
Imatinib | ENSG00000222043 | sensitive | -1.9192 | 0.0043 | ||
Imatinib | ENSG00000223692 | DIP2A-IT1 | sensitive | -1.763 | 0.0203 | |
Imatinib | ENSG00000223764 | LINC02593 | resistant | 5.0279 | 0.0307 | |
Imatinib | ENSG00000223768 | LINC00205 | sensitive | -1.3103 | 0.011 | |
Imatinib | ENSG00000224020 | MIR181A2HG | sensitive | -2.0156 | 0.0465 | |
Imatinib | ENSG00000224043 | CCNT2-AS1 | sensitive | -1.2105 | 0.0246 | |
Imatinib | ENSG00000224086 | PPM1F-AS1 | sensitive | -2.6457 | 0.0433 | |
Imatinib | ENSG00000224093 | BCAR3-AS1 | sensitive | -2.0339 | 0.0338 | |
Imatinib | ENSG00000224216 | sensitive | -1.1436 | 0.0286 | ||
Imatinib | ENSG00000224223 | VSTM2A-OT1 | sensitive | -6.2099 | 0.0379 | |
Imatinib | ENSG00000224251 | sensitive | -2.3028 | 0.0095 | ||
Imatinib | ENSG00000224276 | ARHGEF2-AS1 | sensitive | -2.5168 | 0.0061 | |
Imatinib | ENSG00000224307 | LINC02975 | resistant | 2.4963 | 0.0446 | |
Imatinib | ENSG00000224533 | TMLHE-AS1 | sensitive | -1.6618 | 0.0088 | |
Imatinib | ENSG00000224596 | ZMIZ1-AS1 | sensitive | -3.5259 | 0.0414 | |
Imatinib | ENSG00000224790 | HLCS-AS1 | sensitive | -1.1516 | 0.0155 | |
Imatinib | ENSG00000224844 | sensitive | -4.5849 | 0.0448 | ||
Imatinib | ENSG00000224914 | LINC00863 | sensitive | -1.0931 | 0.0347 | |
Imatinib | ENSG00000224977 | RC3H1-DT | sensitive | -2.3991 | 0.0121 | |
Imatinib | ENSG00000224985 | resistant | 3.9674 | 0.0368 | ||
Imatinib | ENSG00000225075 | sensitive | -1.0873 | 0.0376 | ||
Imatinib | ENSG00000225138 | SLC9A3-AS1 | sensitive | -2.4953 | 0.019 | |
Imatinib | ENSG00000225328 | LINC01594 | resistant | 2.0652 | 0.041 | |
Imatinib | ENSG00000225376 | TMEM246-AS1 | sensitive | -2.8483 | 0.0351 | |
Imatinib | ENSG00000225393 | sensitive | -1.201 | 0.0413 | ||
Imatinib | ENSG00000225555 | sensitive | -1.8341 | 0.0219 | ||
Imatinib | ENSG00000225783 | MIAT | sensitive | -1.9656 | 0.0309 | |
Imatinib | ENSG00000225914 | TSBP1-AS1 | resistant | 2.6064 | 0.0087 | |
Imatinib | ENSG00000226245 | ZNF32-AS1 | sensitive | -1.164 | 0.0273 | |
Imatinib | ENSG00000226330 | PPP1R15B-AS1 | sensitive | -2.614 | 0.0107 | |
Imatinib | ENSG00000226380 | MIR29A | resistant | 2.4306 | 0.0377 | |
Imatinib | ENSG00000226877 | sensitive | -1.2898 | 0.0163 | ||
Imatinib | ENSG00000226944 | RNF207-AS1 | sensitive | -1.5632 | 0.0444 | |
Imatinib | ENSG00000227036 | LINC00511 | sensitive | -3.0987 | 0.0047 | |
Imatinib | ENSG00000227245 | sensitive | -1.3736 | 0.0429 | ||
Imatinib | ENSG00000227352 | ARHGEF7-AS1 | sensitive | -3.0812 | 0.0437 | |
Imatinib | ENSG00000227354 | RBM26-AS1 | sensitive | -2.1857 | 0.0355 | |
Imatinib | ENSG00000227627 | sensitive | -1.0519 | 0.0251 | ||
Imatinib | ENSG00000227646 | STEAP2-AS1 | resistant | 1.8413 | 0.0422 | |
Imatinib | ENSG00000227704 | sensitive | -2.6616 | 0.0255 | ||
Imatinib | ENSG00000227959 | EPHA2-AS1 | resistant | 2.1641 | 0.0047 | |
Imatinib | ENSG00000228016 | RAPGEF4-AS1 | sensitive | -1.7473 | 0.0095 | |
Imatinib | ENSG00000228084 | sensitive | -2.8439 | 0.0385 | ||
Imatinib | ENSG00000228135 | LINC01494 | sensitive | -2.1012 | 0.0262 | |
Imatinib | ENSG00000228137 | MCM3AP-AS1 | sensitive | -1.4737 | 0.0383 | |
Imatinib | ENSG00000228389 | sensitive | -1.877 | 0.0117 | ||
Imatinib | ENSG00000228436 | RRAGC-DT | resistant | 2.8466 | 0.0397 | |
Imatinib | ENSG00000228486 | C2orf92 | sensitive | -1.4549 | 0.0079 | |
Imatinib | ENSG00000228817 | BACH1-IT2 | sensitive | -1.4965 | 0.0235 | |
Imatinib | ENSG00000228857 | ACTR3-AS1 | sensitive | -2.6107 | 0.0448 | |
Imatinib | ENSG00000228906 | JPX | sensitive | -1.6248 | 0.0022 | |
Imatinib | ENSG00000229140 | CCDC26 | resistant | 2.9658 | 0.0308 | |
Imatinib | ENSG00000229444 | ST3GAL3-AS1 | resistant | 1.5616 | 0.0342 | |
Imatinib | ENSG00000229512 | resistant | 1.1864 | 0.0445 | ||
Imatinib | ENSG00000229589 | ACVR2B-AS1 | sensitive | -1.9227 | 0.0482 | |
Imatinib | ENSG00000229656 | ITGB1-DT | resistant | 2.4899 | 0.0058 | |
Imatinib | ENSG00000229660 | resistant | 1.8624 | 0.0326 | ||
Imatinib | ENSG00000229751 | sensitive | -3.4668 | 0.0364 | ||
Imatinib | ENSG00000229915 | resistant | 2.3779 | 0.0348 | ||
Imatinib | ENSG00000230084 | ZBTB47-AS1 | sensitive | -1.3384 | 0.0378 | |
Imatinib | ENSG00000230303 | sensitive | -1.6703 | 0.0131 | ||
Imatinib | ENSG00000230366 | DSCR9 | sensitive | -1.6844 | 0.0153 | |
Imatinib | ENSG00000230534 | resistant | 1.9487 | 0.0029 | ||
Imatinib | ENSG00000230536 | sensitive | -2.3452 | 0.0122 | ||
Imatinib | ENSG00000230552 | sensitive | -2.0594 | 0.0482 | ||
Imatinib | ENSG00000230565 | ZNF32-AS2 | sensitive | -1.1944 | 0.0201 | |
Imatinib | ENSG00000230641 | USP12-DT | resistant | 2.3789 | 0.0317 | |
Imatinib | ENSG00000230699 | sensitive | -2.2651 | 0.0007 | ||
Imatinib | ENSG00000230826 | resistant | 1.239 | 0.0326 | ||
Imatinib | ENSG00000231092 | resistant | 2.7891 | 0.0105 | ||
Imatinib | ENSG00000231121 | sensitive | -2.4365 | 0.0257 | ||
Imatinib | ENSG00000231154 | MORF4L2-AS1 | sensitive | -1.8347 | 0.0199 | |
Imatinib | ENSG00000231187 | SYT15-AS1 | resistant | 3.0509 | 0.0203 | |
Imatinib | ENSG00000231217 | sensitive | -2.166 | 0.0285 | ||
Imatinib | ENSG00000231346 | LINC01160 | sensitive | -1.4612 | 0.0442 | |
Imatinib | ENSG00000231566 | LINC02595 | resistant | 1.7423 | 0.0177 | |
Imatinib | ENSG00000231612 | sensitive | -2.1765 | 0.0065 | ||
Imatinib | ENSG00000231616 | sensitive | -1.1106 | 0.0345 | ||
Imatinib | ENSG00000231728 | TMSB15B-AS1 | sensitive | -1.9448 | 0.0399 | |
Imatinib | ENSG00000231789 | PIK3CD-AS2 | resistant | 1.9955 | 0.0278 | |
Imatinib | ENSG00000231948 | HS1BP3-IT1 | resistant | 2.3863 | 0.0415 | |
Imatinib | ENSG00000231969 | MMADHC-DT | sensitive | -2.4639 | 0.015 | |
Imatinib | ENSG00000231976 | FAM238B | sensitive | -4.4969 | 0.0384 | |
Imatinib | ENSG00000231999 | LRRC8C-DT | resistant | 1.6056 | 0.035 | |
Imatinib | ENSG00000232118 | BACH1-AS1 | sensitive | -1.4322 | 0.0017 | |
Imatinib | ENSG00000232354 | VIPR1-AS1 | sensitive | -1.3184 | 0.0297 | |
Imatinib | ENSG00000232445 | EMSLR | resistant | 2.9548 | 0.0381 | |
Imatinib | ENSG00000232520 | GCSIR | sensitive | -2.3127 | 0.0179 | |
Imatinib | ENSG00000232533 | FAM131B-AS2 | resistant | 2.4606 | 0.0424 | |
Imatinib | ENSG00000232536 | sensitive | -1.8511 | 0.0408 | ||
Imatinib | ENSG00000232618 | HIVEP2-DT | resistant | 3.4879 | 0.0395 | |
Imatinib | ENSG00000232618 | HIVEP2-DT | sensitive | -2.9123 | 0.0392 | |
Imatinib | ENSG00000232638 | sensitive | -2.1239 | 0.0464 | ||
Imatinib | ENSG00000232640 | sensitive | -2.6268 | 0.0237 | ||
Imatinib | ENSG00000232686 | sensitive | -3.3107 | 0.0389 | ||
Imatinib | ENSG00000232973 | CYP1B1-AS1 | sensitive | -2.7477 | 0.0374 | |
Imatinib | ENSG00000233008 | LINC01725 | sensitive | -3.5776 | 0.0061 | |
Imatinib | ENSG00000233080 | LINC01399 | sensitive | -1.9975 | 0.0233 | |
Imatinib | ENSG00000233108 | GLCCI1-DT | sensitive | -3.3321 | 0.0399 | |
Imatinib | ENSG00000233237 | LINC00472 | resistant | 2.5859 | 0.0072 | |
Imatinib | ENSG00000233251 | sensitive | -4.0048 | 0.041 | ||
Imatinib | ENSG00000233621 | ZC3H12A-DT | resistant | 1.8569 | 0.0146 | |
Imatinib | ENSG00000233757 | ZNF892 | sensitive | -1.2538 | 0.0234 | |
Imatinib | ENSG00000233845 | resistant | 2.1886 | 0.0119 | ||
Imatinib | ENSG00000233878 | RNF32-DT | resistant | 2.7035 | 0.0488 | |
Imatinib | ENSG00000233895 | RIN2 | resistant | 4.9685 | 0.002 | |
Imatinib | ENSG00000233895 | RIN2 | sensitive | -1.3667 | 0.0474 | |
Imatinib | ENSG00000234418 | FEZF1-AS1 | resistant | 1.8316 | 0.0368 | |
Imatinib | ENSG00000234571 | H2BP2 | resistant | 2.3792 | 0.0208 | |
Imatinib | ENSG00000234617 | SNRK-AS1 | sensitive | -1.531 | 0.0406 | |
Imatinib | ENSG00000234678 | ELF3-AS1 | sensitive | -2.1184 | 0.026 | |
Imatinib | ENSG00000234694 | CDC20-DT | resistant | 1.5952 | 0.0453 | |
Imatinib | ENSG00000234807 | LINC01135 | resistant | 1.3736 | 0.0329 | |
Imatinib | ENSG00000235100 | sensitive | -1.9565 | 0.0485 | ||
Imatinib | ENSG00000235138 | sensitive | -1.5259 | 0.0159 | ||
Imatinib | ENSG00000235138 | resistant | 1.5305 | 0.0404 | ||
Imatinib | ENSG00000235209 | resistant | 2.8391 | 0.0329 | ||
Imatinib | ENSG00000235296 | sensitive | -2.1911 | 0.0226 | ||
Imatinib | ENSG00000235335 | B3GALT1-AS1 | sensitive | -1.4178 | 0.0354 | |
Imatinib | ENSG00000235397 | EPN2-AS1 | sensitive | -1.0594 | 0.0364 | |
Imatinib | ENSG00000235410 | sensitive | -2.2574 | 0.0198 | ||
Imatinib | ENSG00000235494 | sensitive | -4.1678 | 0.0208 | ||
Imatinib | ENSG00000235545 | DOCK7-DT | sensitive | -1.2086 | 0.0367 | |
Imatinib | ENSG00000235590 | GNAS-AS1 | resistant | 3.3701 | 0.0211 | |
Imatinib | ENSG00000235884 | LINC00941 | sensitive | -1.3003 | 0.0411 | |
Imatinib | ENSG00000235903 | CPB2-AS1 | sensitive | -2.6898 | 0.0209 | |
Imatinib | ENSG00000236051 | MYCBP2-AS1 | sensitive | -3.1402 | 0.01 | |
Imatinib | ENSG00000236098 | resistant | 3.6375 | 0.0003 | ||
Imatinib | ENSG00000236404 | VLDLR-AS1 | sensitive | -3.1246 | 0.0458 | |
Imatinib | ENSG00000236423 | LINC01134 | resistant | 3.233 | 0.0199 | |
Imatinib | ENSG00000236432 | MFF-DT | sensitive | -1.4644 | 0.0069 | |
Imatinib | ENSG00000236463 | LINC00427 | sensitive | -2.2879 | 0.0055 | |
Imatinib | ENSG00000236526 | BTBD3-AS1 | sensitive | -1.5264 | 0.0252 | |
Imatinib | ENSG00000236743 | sensitive | -1.4561 | 0.0078 | ||
Imatinib | ENSG00000236743 | resistant | 1.7749 | 0.0372 | ||
Imatinib | ENSG00000236824 | BCYRN1 | sensitive | -2.4929 | 0.0192 | |
Imatinib | ENSG00000236833 | sensitive | -1.9045 | 0.0352 | ||
Imatinib | ENSG00000236869 | ZKSCAN7-AS1 | sensitive | -1.8081 | 0.0218 | |
Imatinib | ENSG00000236901 | MIR600HG | sensitive | -1.4554 | 0.0418 | |
Imatinib | ENSG00000236914 | LINC01852 | resistant | 2.2175 | 0.0225 | |
Imatinib | ENSG00000236977 | ANKRD44-IT1 | sensitive | -2.3063 | 0.0399 | |
Imatinib | ENSG00000237073 | sensitive | -2.3507 | 0.0264 | ||
Imatinib | ENSG00000237416 | sensitive | -3.0306 | 0.0229 | ||
Imatinib | ENSG00000237756 | sensitive | -1.8927 | 0.0168 | ||
Imatinib | ENSG00000237805 | sensitive | -1.7514 | 0.0468 | ||
Imatinib | ENSG00000237819 | CDK6-AS1 | sensitive | -1.2538 | 0.0399 | |
Imatinib | ENSG00000237838 | sensitive | -3.9083 | 0.0223 | ||
Imatinib | ENSG00000237852 | resistant | 3.147 | 0.0015 | ||
Imatinib | ENSG00000237883 | DGUOK-AS1 | sensitive | -1.3918 | 0.0402 | |
Imatinib | ENSG00000237976 | RFX5-AS1 | sensitive | -1.9725 | 0.0211 | |
Imatinib | ENSG00000238018 | SPTBN1-AS2 | sensitive | -1.5664 | 0.0189 | |
Imatinib | ENSG00000238123 | MID1IP1-AS1 | sensitive | -1.1404 | 0.0461 | |
Imatinib | ENSG00000238141 | BRWD1-AS1 | sensitive | -3.6637 | 0.0225 | |
Imatinib | ENSG00000238272 | sensitive | -2.2007 | 0.0349 | ||
Imatinib | ENSG00000239462 | sensitive | -2.0585 | 0.0295 | ||
Imatinib | ENSG00000240050 | DSE | sensitive | -1.5202 | 0.011 | |
Imatinib | ENSG00000240350 | SOCAR | resistant | 2.317 | 0.0042 | |
Imatinib | ENSG00000240758 | HILPDA-AS1 | sensitive | -1.7613 | 0.0041 | |
Imatinib | ENSG00000241180 | sensitive | -2.1378 | 0.0016 | ||
Imatinib | ENSG00000241219 | sensitive | -1.6962 | 0.0451 | ||
Imatinib | ENSG00000241990 | PRR34-AS1 | resistant | 1.2965 | 0.0318 | |
Imatinib | ENSG00000241990 | PRR34-AS1 | sensitive | -1.3615 | 0.0376 | |
Imatinib | ENSG00000242258 | LINC00996 | sensitive | -1.9964 | 0.026 | |
Imatinib | ENSG00000242553 | DSCR9 | sensitive | -1.7577 | 0.0027 | |
Imatinib | ENSG00000242622 | GSK3B-DT | sensitive | -1.1664 | 0.0239 | |
Imatinib | ENSG00000242791 | PFN2-AS1 | sensitive | -1.7362 | 0.0049 | |
Imatinib | ENSG00000243144 | LINC02932 | sensitive | -2.8752 | 0.0158 | |
Imatinib | ENSG00000243350 | sensitive | -2.4024 | 0.0427 | ||
Imatinib | ENSG00000243368 | MCCC1-AS1 | resistant | 1.6351 | 0.0439 | |
Imatinib | ENSG00000243533 | TBCE-AS1 | sensitive | -1.5277 | 0.012 | |
Imatinib | ENSG00000243637 | resistant | 2.6541 | 0.0354 | ||
Imatinib | ENSG00000243902 | resistant | 2.9578 | 0.0436 | ||
Imatinib | ENSG00000244541 | LINC01213 | resistant | 2.09 | 0.0379 | |
Imatinib | ENSG00000244625 | MIATNB | sensitive | -1.4166 | 0.0339 | |
Imatinib | ENSG00000245573 | BDNF-AS | sensitive | -1.2728 | 0.0394 | |
Imatinib | ENSG00000245598 | DACT3-AS1 | sensitive | -3.391 | 0.0408 | |
Imatinib | ENSG00000245685 | FRG1-DT | sensitive | -1.7821 | 0.0434 | |
Imatinib | ENSG00000246465 | sensitive | -2.8145 | 0.0257 | ||
Imatinib | ENSG00000246560 | UBE2D3-AS1 | sensitive | -1.1958 | 0.0418 | |
Imatinib | ENSG00000246792 | sensitive | -2.3791 | 0.0212 | ||
Imatinib | ENSG00000246859 | STARD4-AS1 | sensitive | -2.0132 | 0.0277 | |
Imatinib | ENSG00000246877 | DNM1P35 | sensitive | -1.4941 | 0.04 | |
Imatinib | ENSG00000247134 | sensitive | -2.6598 | 0.037 | ||
Imatinib | ENSG00000247516 | MIR4458HG | sensitive | -1.1662 | 0.0081 | |
Imatinib | ENSG00000247556 | OIP5-AS1 | sensitive | -1.5544 | 0.0302 | |
Imatinib | ENSG00000247572 | CKMT2-AS1 | sensitive | -1.0274 | 0.0417 | |
Imatinib | ENSG00000248240 | C5orf34-AS1 | sensitive | -1.5902 | 0.0421 | |
Imatinib | ENSG00000248476 | BACH1-IT1 | sensitive | -1.3282 | 0.027 | |
Imatinib | ENSG00000248677 | LINC02102 | sensitive | -1.7206 | 0.0467 | |
Imatinib | ENSG00000249085 | TNPO1-DT | sensitive | -2.8149 | 0.0343 | |
Imatinib | ENSG00000249430 | sensitive | -3.979 | 0.0312 | ||
Imatinib | ENSG00000249593 | sensitive | -2.8467 | 0.0329 | ||
Imatinib | ENSG00000249610 | ZNF474-AS1 | sensitive | -1.6425 | 0.0233 | |
Imatinib | ENSG00000249635 | sensitive | -1.6117 | 0.0222 | ||
Imatinib | ENSG00000249655 | sensitive | -1.1755 | 0.0493 | ||
Imatinib | ENSG00000249664 | resistant | 1.2583 | 0.0401 | ||
Imatinib | ENSG00000249673 | NOP14-AS1 | resistant | 1.0839 | 0.037 | |
Imatinib | ENSG00000250106 | ANKRD33B-AS1 | resistant | 2.4432 | 0.0065 | |
Imatinib | ENSG00000250132 | sensitive | -1.3604 | 0.0208 | ||
Imatinib | ENSG00000250220 | ANKRD17-DT | sensitive | -1.6627 | 0.0234 | |
Imatinib | ENSG00000250240 | sensitive | -2.5798 | 0.0363 | ||
Imatinib | ENSG00000250250 | resistant | 2.018 | 0.0385 | ||
Imatinib | ENSG00000250410 | LRP2BP-AS1 | sensitive | -2.6419 | 0.0009 | |
Imatinib | ENSG00000250714 | TNFRSF10A-DT | resistant | 1.3813 | 0.0483 | |
Imatinib | ENSG00000250802 | ZBED3-AS1 | sensitive | -1.681 | 0.031 | |
Imatinib | ENSG00000250889 | resistant | 2.5259 | 0.0189 | ||
Imatinib | ENSG00000250900 | TRIM7-AS1 | resistant | 2.1965 | 0.014 | |
Imatinib | ENSG00000250948 | ZNF652-AS1 | sensitive | -1.901 | 0.032 | |
Imatinib | ENSG00000251034 | sensitive | -1.8635 | 0.0126 | ||
Imatinib | ENSG00000251054 | sensitive | -2.6794 | 0.0207 | ||
Imatinib | ENSG00000251141 | MRPS30-DT | sensitive | -1.6866 | 0.0047 | |
Imatinib | ENSG00000251432 | LINC02615 | sensitive | -1.647 | 0.0188 | |
Imatinib | ENSG00000251613 | LINC02056 | sensitive | -4.1346 | 0.0104 | |
Imatinib | ENSG00000253174 | resistant | 2.1962 | 0.0179 | ||
Imatinib | ENSG00000253174 | sensitive | -1.8859 | 0.014 | ||
Imatinib | ENSG00000253559 | OSGEPL1-AS1 | sensitive | -1.791 | 0.0325 | |
Imatinib | ENSG00000253671 | MTUS1-DT | resistant | 2.6087 | 0.025 | |
Imatinib | ENSG00000253764 | KBTBD11-AS1 | sensitive | -2.5771 | 0.0293 | |
Imatinib | ENSG00000253865 | sensitive | -2.9041 | 0.0436 | ||
Imatinib | ENSG00000253917 | resistant | 1.091 | 0.0162 | ||
Imatinib | ENSG00000253930 | TNFRSF10A-AS1 | resistant | 1.6217 | 0.0202 | |
Imatinib | ENSG00000253955 | LINC02995 | sensitive | -1.4029 | 0.042 | |
Imatinib | ENSG00000254035 | sensitive | -2.56 | 0.0461 | ||
Imatinib | ENSG00000254207 | sensitive | -2.41 | 0.0454 | ||
Imatinib | ENSG00000254459 | sensitive | -2.09 | 0.0313 | ||
Imatinib | ENSG00000254510 | sensitive | -2.4177 | 0.0193 | ||
Imatinib | ENSG00000254761 | sensitive | -1.9896 | 0.0392 | ||
Imatinib | ENSG00000254812 | sensitive | -1.9679 | 0.0129 | ||
Imatinib | ENSG00000254990 | sensitive | -1.4059 | 0.0474 | ||
Imatinib | ENSG00000255160 | sensitive | -2.1549 | 0.0399 | ||
Imatinib | ENSG00000255176 | sensitive | -1.1513 | 0.0212 | ||
Imatinib | ENSG00000255310 | sensitive | -2.3699 | 0.0035 | ||
Imatinib | ENSG00000255669 | sensitive | -1.6629 | 0.0124 | ||
Imatinib | ENSG00000255921 | resistant | 2.2598 | 0.0254 | ||
Imatinib | ENSG00000255992 | PUS1-AS1 | resistant | 1.0899 | 0.0127 | |
Imatinib | ENSG00000256312 | resistant | 2.7682 | 0.0073 | ||
Imatinib | ENSG00000256360 | sensitive | -1.982 | 0.0413 | ||
Imatinib | ENSG00000256897 | resistant | 1.9038 | 0.0226 | ||
Imatinib | ENSG00000257086 | resistant | 3.1291 | 0.0141 | ||
Imatinib | ENSG00000257135 | ODC1-DT | resistant | 1.7596 | 0.0229 | |
Imatinib | ENSG00000257660 | ADCY6-DT | sensitive | -1.7392 | 0.023 | |
Imatinib | ENSG00000257696 | UHRF1BP1L-DT | sensitive | -1.1713 | 0.0127 | |
Imatinib | ENSG00000257999 | sensitive | -2.3676 | 0.0314 | ||
Imatinib | ENSG00000258344 | resistant | 1.202 | 0.017 | ||
Imatinib | ENSG00000258441 | LINC00641 | sensitive | -1.7947 | 0.0264 | |
Imatinib | ENSG00000258458 | OXA1L-DT | sensitive | -1.0823 | 0.0471 | |
Imatinib | ENSG00000258471 | sensitive | -3.3845 | 0.0494 | ||
Imatinib | ENSG00000258766 | DIO2-AS1 | sensitive | -1.6821 | 0.0098 | |
Imatinib | ENSG00000258825 | sensitive | -1.1079 | 0.0351 | ||
Imatinib | ENSG00000258902 | resistant | 2.6914 | 0.0397 | ||
Imatinib | ENSG00000258904 | sensitive | -1.0854 | 0.0465 | ||
Imatinib | ENSG00000258983 | resistant | 3.221 | 0.0102 | ||
Imatinib | ENSG00000259039 | sensitive | -2.6104 | 0.0163 | ||
Imatinib | ENSG00000259153 | MAP3K9-DT | sensitive | -1.1138 | 0.0085 | |
Imatinib | ENSG00000259158 | ADAM20P1 | sensitive | -1.9597 | 0.0325 | |
Imatinib | ENSG00000259172 | SNRPA1-DT | sensitive | -1.4021 | 0.0233 | |
Imatinib | ENSG00000259209 | resistant | 2.2889 | 0.0462 | ||
Imatinib | ENSG00000259244 | UBE2Q2P1 | sensitive | -1.4404 | 0.0119 | |
Imatinib | ENSG00000259345 | sensitive | -2.139 | 0.0358 | ||
Imatinib | ENSG00000259548 | sensitive | -3.0168 | 0.0172 | ||
Imatinib | ENSG00000259635 | sensitive | -2.119 | 0.0367 | ||
Imatinib | ENSG00000259712 | sensitive | -1.9864 | 0.0474 | ||
Imatinib | ENSG00000259782 | resistant | 1.2751 | 0.0477 | ||
Imatinib | ENSG00000259783 | LINC02259 | sensitive | -1.2145 | 0.0192 | |
Imatinib | ENSG00000259953 | LINC02977 | sensitive | -1.5971 | 0.0444 | |
Imatinib | ENSG00000259954 | IL21R-AS1 | sensitive | -3.6031 | 0.0464 | |
Imatinib | ENSG00000260006 | sensitive | -1.511 | 0.0309 | ||
Imatinib | ENSG00000260034 | LCMT1-AS2 | sensitive | -1.721 | 0.0127 | |
Imatinib | ENSG00000260059 | resistant | 1.9113 | 0.0145 | ||
Imatinib | ENSG00000260176 | sensitive | -1.5275 | 0.0434 | ||
Imatinib | ENSG00000260186 | LINC02137 | sensitive | -2.6393 | 0.0068 | |
Imatinib | ENSG00000260293 | sensitive | -2.339 | 0.0359 | ||
Imatinib | ENSG00000260329 | TMEM263-DT | resistant | 1.9873 | 0.0447 | |
Imatinib | ENSG00000260361 | sensitive | -1.6754 | 0.0162 | ||
Imatinib | ENSG00000260368 | resistant | 1.6197 | 0.0329 | ||
Imatinib | ENSG00000260420 | LINC02182 | sensitive | -3.4612 | 0.047 | |
Imatinib | ENSG00000260578 | sensitive | -2.3183 | 0.0233 | ||
Imatinib | ENSG00000260614 | sensitive | -3.2689 | 0.0489 | ||
Imatinib | ENSG00000260630 | SNAI3-AS1 | resistant | 3.6584 | 0.0165 | |
Imatinib | ENSG00000260804 | LINC01963 | sensitive | -2.0712 | 0.0376 | |
Imatinib | ENSG00000260830 | sensitive | -1.0554 | 0.0219 | ||
Imatinib | ENSG00000260831 | sensitive | -1.3275 | 0.0496 | ||
Imatinib | ENSG00000260874 | sensitive | -1.7047 | 0.0474 | ||
Imatinib | ENSG00000260884 | sensitive | -1.8255 | 0.0407 | ||
Imatinib | ENSG00000260927 | sensitive | -1.2414 | 0.0328 | ||
Imatinib | ENSG00000260931 | sensitive | -2.8815 | 0.0296 | ||
Imatinib | ENSG00000260949 | sensitive | -2.8646 | 0.0126 | ||
Imatinib | ENSG00000261140 | sensitive | -1.0954 | 0.0421 | ||
Imatinib | ENSG00000261167 | sensitive | -2.0002 | 0.0045 | ||
Imatinib | ENSG00000261288 | sensitive | -1.5968 | 0.0361 | ||
Imatinib | ENSG00000261428 | sensitive | -2.169 | 0.0371 | ||
Imatinib | ENSG00000261447 | sensitive | -2.4007 | 0.0333 | ||
Imatinib | ENSG00000261533 | sensitive | -2.2768 | 0.0038 | ||
Imatinib | ENSG00000261613 | sensitive | -1.5353 | 0.0448 | ||
Imatinib | ENSG00000261654 | sensitive | -2.4365 | 0.0499 | ||
Imatinib | ENSG00000261670 | sensitive | -2.4651 | 0.0472 | ||
Imatinib | ENSG00000261673 | sensitive | -2.3516 | 0.0367 | ||
Imatinib | ENSG00000261770 | LINC00662 | sensitive | -1.3264 | 0.0436 | |
Imatinib | ENSG00000261798 | resistant | 2.376 | 0.0434 | ||
Imatinib | ENSG00000261839 | sensitive | -1.0884 | 0.031 | ||
Imatinib | ENSG00000262094 | resistant | 1.9372 | 0.0378 | ||
Imatinib | ENSG00000262172 | sensitive | -3.5939 | 0.0444 | ||
Imatinib | ENSG00000262228 | resistant | 1.53 | 0.0074 | ||
Imatinib | ENSG00000262721 | sensitive | -1.5391 | 0.017 | ||
Imatinib | ENSG00000263011 | sensitive | -1.771 | 0.0323 | ||
Imatinib | ENSG00000263220 | sensitive | -1.3583 | 0.0178 | ||
Imatinib | ENSG00000263220 | sensitive | -2.176 | 0.0378 | ||
Imatinib | ENSG00000263551 | sensitive | -1.7834 | 0.0235 | ||
Imatinib | ENSG00000263567 | resistant | 1.528 | 0.0418 | ||
Imatinib | ENSG00000263612 | sensitive | -1.8828 | 0.0342 | ||
Imatinib | ENSG00000263680 | sensitive | -2.2342 | 0.0048 | ||
Imatinib | ENSG00000264167 | sensitive | -2.0254 | 0.035 | ||
Imatinib | ENSG00000264222 | sensitive | -4.0467 | 0.0407 | ||
Imatinib | ENSG00000264520 | sensitive | -1.3037 | 0.0404 | ||
Imatinib | ENSG00000264575 | LINC00526 | resistant | 1.1477 | 0.0101 | |
Imatinib | ENSG00000264735 | sensitive | -2.1328 | 0.0099 | ||
Imatinib | ENSG00000264812 | resistant | 2.1653 | 0.0061 | ||
Imatinib | ENSG00000264937 | sensitive | -1.4091 | 0.0358 | ||
Imatinib | ENSG00000265218 | sensitive | -1.8534 | 0.0399 | ||
Imatinib | ENSG00000265282 | sensitive | -2.1366 | 0.0279 | ||
Imatinib | ENSG00000265443 | sensitive | -1.8194 | 0.0426 | ||
Imatinib | ENSG00000266644 | sensitive | -1.1561 | 0.036 | ||
Imatinib | ENSG00000266936 | resistant | 2.0293 | 0.0196 | ||
Imatinib | ENSG00000266970 | SOCS3-DT | sensitive | -1.8206 | 0.0483 | |
Imatinib | ENSG00000267093 | resistant | 1.0584 | 0.0188 | ||
Imatinib | ENSG00000267152 | sensitive | -1.0963 | 0.0329 | ||
Imatinib | ENSG00000267167 | sensitive | -1.5019 | 0.0466 | ||
Imatinib | ENSG00000267172 | sensitive | -2.3107 | 0.0285 | ||
Imatinib | ENSG00000267201 | LINC01775 | sensitive | -1.5157 | 0.0177 | |
Imatinib | ENSG00000267201 | LINC01775 | resistant | 2.0138 | 0.041 | |
Imatinib | ENSG00000267231 | sensitive | -2.8225 | 0.0274 | ||
Imatinib | ENSG00000267372 | resistant | 3.1631 | 0.0384 | ||
Imatinib | ENSG00000267491 | resistant | 1.4547 | 0.0121 | ||
Imatinib | ENSG00000267519 | MIR23AHG | resistant | 3.06 | 0.0301 | |
Imatinib | ENSG00000267565 | sensitive | -2.1573 | 0.0207 | ||
Imatinib | ENSG00000267588 | MIR1302-2 | sensitive | -3.0424 | 0.0427 | |
Imatinib | ENSG00000267613 | sensitive | -2.0455 | 0.0336 | ||
Imatinib | ENSG00000267640 | sensitive | -4.1332 | 0.0037 | ||
Imatinib | ENSG00000267898 | sensitive | -1.3736 | 0.0072 | ||
Imatinib | ENSG00000267934 | sensitive | -2.526 | 0.02 | ||
Imatinib | ENSG00000268015 | sensitive | -1.5281 | 0.0229 | ||
Imatinib | ENSG00000268049 | A1BG-AS1 | sensitive | -1.2378 | 0.0354 | |
Imatinib | ENSG00000268262 | sensitive | -2.0961 | 0.0477 | ||
Imatinib | ENSG00000268266 | sensitive | -2.1389 | 0.0483 | ||
Imatinib | ENSG00000268583 | sensitive | -1.6368 | 0.0144 | ||
Imatinib | ENSG00000268756 | sensitive | -1.3774 | 0.0326 | ||
Imatinib | ENSG00000268912 | sensitive | -1.3099 | 0.0076 | ||
Imatinib | ENSG00000269102 | sensitive | -1.4313 | 0.0023 | ||
Imatinib | ENSG00000269220 | LINC00528 | sensitive | -1.7808 | 0.0335 | |
Imatinib | ENSG00000269653 | sensitive | -1.7454 | 0.0362 | ||
Imatinib | ENSG00000269918 | sensitive | -2.2171 | 0.0049 | ||
Imatinib | ENSG00000269956 | MKNK1-AS1 | sensitive | -1.3683 | 0.0096 | |
Imatinib | ENSG00000269959 | SPACA6-AS1 | sensitive | -1.0601 | 0.0228 | |
Imatinib | ENSG00000269976 | resistant | 2.6853 | 0.0112 | ||
Imatinib | ENSG00000269983 | GTF2H2B | sensitive | -1.9273 | 0.0076 | |
Imatinib | ENSG00000270018 | sensitive | -1.8263 | 0.0075 | ||
Imatinib | ENSG00000270039 | sensitive | -1.5061 | 0.0089 | ||
Imatinib | ENSG00000270091 | sensitive | -1.0373 | 0.0309 | ||
Imatinib | ENSG00000270223 | sensitive | -1.4901 | 0.0045 | ||
Imatinib | ENSG00000270599 | sensitive | -3.3093 | 0.0457 | ||
Imatinib | ENSG00000270704 | SNORD64 | sensitive | -2.0289 | 0.0318 | |
Imatinib | ENSG00000270996 | sensitive | -1.7714 | 0.0471 | ||
Imatinib | ENSG00000271009 | sensitive | -1.5587 | 0.0304 | ||
Imatinib | ENSG00000271147 | ARMCX5-GPRASP2 | sensitive | -1.3041 | 0.0254 | |
Imatinib | ENSG00000271228 | resistant | 1.3279 | 0.0299 | ||
Imatinib | ENSG00000271265 | sensitive | -1.3435 | 0.0381 | ||
Imatinib | ENSG00000271314 | resistant | 2.0856 | 0.0202 | ||
Imatinib | ENSG00000271659 | sensitive | -1.3553 | 0.049 | ||
Imatinib | ENSG00000271757 | sensitive | -2.1808 | 0.044 | ||
Imatinib | ENSG00000271782 | sensitive | -1.4414 | 0.0025 | ||
Imatinib | ENSG00000271874 | RAI14-DT | resistant | 1.687 | 0.0498 | |
Imatinib | ENSG00000271927 | sensitive | -1.3536 | 0.0329 | ||
Imatinib | ENSG00000272009 | resistant | 1.3136 | 0.0369 | ||
Imatinib | ENSG00000272024 | PCMTD1-DT | sensitive | -2.6981 | 0.0173 | |
Imatinib | ENSG00000272029 | sensitive | -1.4564 | 0.0222 | ||
Imatinib | ENSG00000272068 | BCAN-AS1 | sensitive | -2.5148 | 0.0497 | |
Imatinib | ENSG00000272070 | sensitive | -1.7191 | 0.0219 | ||
Imatinib | ENSG00000272070 | sensitive | -1.5666 | 0.018 | ||
Imatinib | ENSG00000272076 | sensitive | -2.8597 | 0.0327 | ||
Imatinib | ENSG00000272088 | sensitive | -1.7228 | 0.0354 | ||
Imatinib | ENSG00000272103 | sensitive | -1.7572 | 0.0207 | ||
Imatinib | ENSG00000272137 | sensitive | -1.5167 | 0.0366 | ||
Imatinib | ENSG00000272172 | sensitive | -1.3916 | 0.0036 | ||
Imatinib | ENSG00000272250 | sensitive | -1.2978 | 0.0299 | ||
Imatinib | ENSG00000272263 | sensitive | -1.5498 | 0.0289 | ||
Imatinib | ENSG00000272301 | sensitive | -2.2545 | 0.0304 | ||
Imatinib | ENSG00000272308 | sensitive | -2.5122 | 0.0056 | ||
Imatinib | ENSG00000272335 | sensitive | -1.3051 | 0.0137 | ||
Imatinib | ENSG00000272354 | sensitive | -2.1221 | 0.0398 | ||
Imatinib | ENSG00000272379 | sensitive | -2.1262 | 0.0365 | ||
Imatinib | ENSG00000272438 | sensitive | -1.5006 | 0.0156 | ||
Imatinib | ENSG00000272461 | sensitive | -4.4354 | 0.0175 | ||
Imatinib | ENSG00000272498 | sensitive | -1.126 | 0.0233 | ||
Imatinib | ENSG00000272508 | sensitive | -3.4443 | 0.0356 | ||
Imatinib | ENSG00000272558 | resistant | 3.1557 | 0.0101 | ||
Imatinib | ENSG00000272631 | sensitive | -1.3006 | 0.0208 | ||
Imatinib | ENSG00000272682 | sensitive | -1.1878 | 0.0294 | ||
Imatinib | ENSG00000272690 | LINC02018 | sensitive | -2.315 | 0.0016 | |
Imatinib | ENSG00000272702 | resistant | 1.2442 | 0.008 | ||
Imatinib | ENSG00000272702 | resistant | 1.4963 | 0.0329 | ||
Imatinib | ENSG00000272769 | resistant | 2.2882 | 0.0059 | ||
Imatinib | ENSG00000272791 | sensitive | -1.1969 | 0.042 | ||
Imatinib | ENSG00000272798 | sensitive | -2.7277 | 0.039 | ||
Imatinib | ENSG00000272828 | sensitive | -2.2705 | 0.0237 | ||
Imatinib | ENSG00000272940 | CHKB-DT | sensitive | -4.9812 | 0.0368 | |
Imatinib | ENSG00000272942 | sensitive | -2.5843 | 0.0438 | ||
Imatinib | ENSG00000272950 | resistant | 2.3228 | 0.0178 | ||
Imatinib | ENSG00000272966 | sensitive | -1.7965 | 0.0297 | ||
Imatinib | ENSG00000273017 | sensitive | -1.4328 | 0.0464 | ||
Imatinib | ENSG00000273056 | sensitive | -1.9102 | 0.0013 | ||
Imatinib | ENSG00000273156 | sensitive | -1.3374 | 0.0467 | ||
Imatinib | ENSG00000273181 | sensitive | -1.4729 | 0.0289 | ||
Imatinib | ENSG00000273190 | sensitive | -1.4701 | 0.0046 | ||
Imatinib | ENSG00000273287 | sensitive | -1.7716 | 0.0092 | ||
Imatinib | ENSG00000273306 | sensitive | -1.1563 | 0.0169 | ||
Imatinib | ENSG00000273342 | resistant | 1.4362 | 0.0043 | ||
Imatinib | ENSG00000273372 | SFTPD-AS1 | sensitive | -3.2076 | 0.0484 | |
Imatinib | ENSG00000273399 | sensitive | -1.2696 | 0.0388 | ||
Imatinib | ENSG00000273402 | resistant | 1.1168 | 0.022 | ||
Imatinib | ENSG00000273402 | sensitive | -2.1835 | 0.0487 | ||
Imatinib | ENSG00000273448 | sensitive | -1.4605 | 0.0161 | ||
Imatinib | ENSG00000273454 | sensitive | -2.2144 | 0.0172 | ||
Imatinib | ENSG00000273473 | sensitive | -1.9507 | 0.0202 |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
---|---|---|---|---|---|---|---|
Imatinib | CDKN2A | lncRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | CCDC26 | lncRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | H19 | lncRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | HOTAIR | lncRNA | up-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-122-5p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-124-3p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-126-3p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1469 | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-146a-5p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-18a-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1915-3p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-193b-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-1972 | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-20a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-21-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-30a-5p | miRNA | up-regulated | Low | Giant Cell Tumor | Homo sapiens | |
Imatinib | hsa-miR-483-3p | miRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | hsa-miR-494-3p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-505-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | hsa-miR-940 | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib | MEG3 | lncRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | mmu-miR-133a-3p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-133b-3p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-1a-3p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-339-3p | miRNA | down-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-3572-5p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-5100 | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6236 | miRNA | down-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6240 | miRNA | down-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6354 | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6378 | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6946-5p | miRNA | down-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-6999-5p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | mmu-miR-7058-5p | miRNA | up-regulated | High | Normal | Mus musculus | |
Imatinib | NBR2 | lncRNA | up-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | NEAT1 | lncRNA | up-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | NED125 | lncRNA | down-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | NED125 | lncRNA | up-regulated | Low | Gastrointestinal Stromal Tumor | Homo sapiens | |
Imatinib | UCA1 | lncRNA | up-regulated | Low | Chronic Myeloid Leukemia | Homo sapiens |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Compound | ncRNA | ncRNA Type | Pattern | log2FC | p-value | Detail |
---|---|---|---|---|---|---|
Imatinib | hsa-let-7f-5p | miRNA | down-regulated | -0.580 | 0.020 | |
Imatinib | hsa-let-7g | miRNA | down-regulated | -0.432 | 0.033 | |
Imatinib | hsa-miR-106a-5p | miRNA | down-regulated | -0.802 | 1.21e-4 | |
Imatinib | hsa-miR-10a-5p | miRNA | down-regulated | -0.424 | 0.009 | |
Imatinib | hsa-miR-1225-5p | miRNA | up-regulated | 1.286 | 5.81e-6 | |
Imatinib | hsa-miR-125a-3p | miRNA | up-regulated | 0.059 | 0.028 | |
Imatinib | hsa-miR-126-3p | miRNA | down-regulated | -1.001 | 5.69e-4 | |
Imatinib | hsa-miR-126-5p | miRNA | down-regulated | -1.046 | 0.029 | |
Imatinib | hsa-miR-1280 | miRNA | down-regulated | -0.096 | 0.049 | |
Imatinib | hsa-miR-130b-3p | miRNA | down-regulated | -0.451 | 7.35e-4 | |
Imatinib | hsa-miR-140-3p | miRNA | up-regulated | 0.199 | 0.042 | |
Imatinib | hsa-miR-144-3p | miRNA | up-regulated | 3.219 | 1.44e-5 | |
Imatinib | hsa-miR-144-5p | miRNA | up-regulated | 1.100 | 0.003 | |
Imatinib | hsa-miR-146b-5p | miRNA | down-regulated | -0.770 | 0.007 | |
Imatinib | hsa-miR-149-5p | miRNA | down-regulated | -0.182 | 0.004 | |
Imatinib | hsa-miR-16-5p | miRNA | up-regulated | 0.518 | 6.29e-4 | |
Imatinib | hsa-miR-17-5p | miRNA | up-regulated | 0.034 | 0.029 | |
Imatinib | hsa-miR-181d-5p | miRNA | down-regulated | -0.222 | 0.010 | |
Imatinib | hsa-miR-183-5p | miRNA | up-regulated | 0.537 | 0.003 | |
Imatinib | hsa-miR-185-5p | miRNA | up-regulated | 0.766 | 3.81e-5 | |
Imatinib | hsa-miR-188-5p | miRNA | up-regulated | 1.154 | 0.005 | |
Imatinib | hsa-miR-18a-5p | miRNA | down-regulated | -0.774 | 0.003 | |
Imatinib | hsa-miR-18b-5p | miRNA | down-regulated | -0.582 | 0.003 | |
Imatinib | hsa-miR-192-5p | miRNA | up-regulated | 0.318 | 0.021 | |
Imatinib | hsa-miR-197-3p | miRNA | up-regulated | 0.145 | 0.003 | |
Imatinib | hsa-miR-19b-1-5p | miRNA | down-regulated | -0.750 | 0.008 | |
Imatinib | hsa-miR-20a-5p | miRNA | up-regulated | 0.053 | 0.007 | |
Imatinib | hsa-miR-21-3p | miRNA | down-regulated | -1.806 | 4.76e-7 | |
Imatinib | hsa-miR-21-5p | miRNA | down-regulated | -0.707 | 4.59e-4 | |
Imatinib | hsa-miR-215-5p | miRNA | up-regulated | 0.642 | 0.014 | |
Imatinib | hsa-miR-223-3p | miRNA | down-regulated | -0.463 | 0.005 | |
Imatinib | hsa-miR-23b-3p | miRNA | up-regulated | 0.076 | 0.023 | |
Imatinib | hsa-miR-27a-3p | miRNA | up-regulated | 0.566 | 0.008 | |
Imatinib | hsa-miR-29a-3p | miRNA | down-regulated | -0.265 | 0.049 | |
Imatinib | hsa-miR-301a-3p | miRNA | up-regulated | 0.197 | 0.017 | |
Imatinib | hsa-miR-30a-3p | miRNA | down-regulated | -0.056 | 0.027 | |
Imatinib | hsa-miR-30d-5p | miRNA | up-regulated | 0.439 | 0.007 | |
Imatinib | hsa-miR-320a-3p | miRNA | up-regulated | 0.061 | 0.039 | |
Imatinib | hsa-miR-320a-3p | miRNA | down-regulated | -0.226 | 0.010 | |
Imatinib | hsa-miR-324-5p | miRNA | down-regulated | -0.061 | 0.019 | |
Imatinib | hsa-miR-324-5p | miRNA | down-regulated | -0.281 | 0.014 | |
Imatinib | hsa-miR-365a-3p | miRNA | down-regulated | -0.413 | 0.044 | |
Imatinib | hsa-miR-423-5p | miRNA | up-regulated | 0.044 | 0.013 | |
Imatinib | hsa-miR-451a | miRNA | up-regulated | 3.474 | 1.60e-5 | |
Imatinib | hsa-miR-483-3p | miRNA | down-regulated | -0.145 | 2.63e-4 | |
Imatinib | hsa-miR-483-5p | miRNA | down-regulated | -0.088 | 0.044 | |
Imatinib | hsa-miR-486-3p | miRNA | up-regulated | 0.720 | 0.007 | |
Imatinib | hsa-miR-486-5p | miRNA | up-regulated | 1.082 | 3.74e-4 | |
Imatinib | hsa-miR-574-5p | miRNA | up-regulated | 0.107 | 0.019 | |
Imatinib | hsa-miR-625-5p | miRNA | down-regulated | -0.584 | 6.19e-4 | |
Imatinib | hsa-miR-630 | miRNA | up-regulated | 2.337 | 6.64e-4 | |
Imatinib | hsa-miR-638 | miRNA | up-regulated | 0.447 | 0.013 | |
Imatinib | hsa-miR-7-5p | miRNA | down-regulated | -1.415 | 4.04e-5 | |
Imatinib | hsa-miR-768-3p | miRNA | down-regulated | -0.444 | 0.003 | |
Imatinib | hsa-miR-768-5p | miRNA | up-regulated | 0.140 | 0.008 | |
Imatinib | hsa-miR-9-3p | miRNA | down-regulated | -0.418 | 9.41e-4 | |
Imatinib | hsa-miR-923 | miRNA | up-regulated | 1.021 | 0.004 | |
Imatinib | hsa-miR-939-5p | miRNA | down-regulated | -0.681 | 0.007 |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Compound | ncRNA | Symbol | Pattern | Instance | Fold change | Detail |
---|---|---|---|---|---|---|
Imatinib | LINC03050 | LINC03050 | down-regulated | 366 | 0.38 | |
Imatinib | AC013391.3 | down-regulated | 366 | 0.45 | ||
Imatinib | KCNK15-AS1 | KCNK15-AS1 | down-regulated | 366 | 0.23 | |
Imatinib | RNASE2CP | RNASE2CP | up-regulated | 366 | 2.25 | |
Imatinib | ATXN8OS | ATXN8OS | down-regulated | 483 | 0.47 | |
Imatinib | LINC00474 | LINC00474 | down-regulated | 366 | 0.45 | |
Imatinib | LINC00574 | LINC00574 | down-regulated | 483 | 0.45 | |
Imatinib | LINC00574 | LINC00574 | down-regulated | 366 | 0.34 | |
Imatinib | MYMX | MYMX | down-regulated | 366 | 0.39 | |
Imatinib | PVT1 | PVT1 | down-regulated | 366 | 0.41 | |
Imatinib | TP53TG1 | TP53TG1 | up-regulated | 483 | 2.51 | |
Imatinib | VASH1-AS1 | VASH1-AS1 | up-regulated | 366 | 2.39 | |
Imatinib | ZNF213-AS1 | ZNF213-AS1 | up-regulated | 366 | 2.08 |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.